The Hematologist
by The Hematologist
Latest episode
One Size Doesn’t Fit All: International Consensus Recommendations…
One Size Doesn’t Fit All: International Consensus Recommendations…
About this podcast
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
Episodes
The newest 20 of 170 episodes
- One Size Doesn’t Fit All: International Consensus Recommendations for Pediatric Acute Myeloid Leukemia · 16 min · Episode 170In this episode, contributing editor Dr. Lauren Pommert speaks with Dr. Sarah Tasian, pediatric oncologist at the Children’s Hospital of Philadelphia. They discuss the new…
- MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma · 24 min · Episode 169In this episode contributing editor Dr. Ajai Chari speaks with Dr. Roberto Mina, assistant professor of Hematology at Emory University about two recent myeloma studies published…
- One on One With Mary Horowitz · 24 min · Episode 168In this episode contributing editor, Lori Muffly, MD, MS, speaks with a celebrated leader in the field of bone marrow transplantation, Mary Horowitz, MD, MS, of the Medical…
- A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma · 22 min · Episode 167In this episode, Contributing Editor, Brian Hill, MD, speaks with Juan Alderuccio, MD, of the University of Miami Cancer Center, about a landmark study that supports refined…
- Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy · 21 min · Episode 166In this episode, Contributing Editor Meera Sridharan, MD, PhD, speaks with Hiroyuki Matsui, MD, PhD, assistant professor in the department of hematology at Kyoto University…
- Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation? · 18 min · Episode 165In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the…
- Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients · 20 min · Episode 164In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill…
- Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia · 22 min · Episode 163In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on…
- VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia · 22 min · Episode 162In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical…
- Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society · 23 min · Episode 161In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and…
- An Homage to the Treg Graft in Allogeneic Transplantation · 23 min · Episode 160In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD…
- Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients · 20 min · Episode 159In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose…
- GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias · 21 min · Episode 158In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco…
- More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia · 23 min · Episode 157In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their…
- Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia · 22 min · Episode 156In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of…
- Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 19 min · Episode 155In this episode, Contributing Editor Scott Furlan, MD, PhD, an assistant professor at the Fred Hutch Cancer Center and Department of Pediatrics at the University of Washington in…
- When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists · 11 min · Episode 154In this episode, Contributing Editor Michael Scott, MD, a hematologist at St. Michael’s Hospital in Toronto, Canada, and an assistant professor at the University of Toronto…
- No Scientific Link Found Between Sickle Cell Trait and Sudden Death · 21 min · Episode 153In this episode, Contributing Editor Samuel Wilson, MD, MSCR, an assistant professor of hematology at the University of North Carolina at Chapel Hill, talks with Michael DeBaun…
- Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin · 20 min · Episode 152In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California…
- The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S. · 26 min · Episode 151In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine at Stanford University where she focuses on cellular therapy for adults with acute…
